Senior Executive Director - Strategic Regulatory Affairs Advanced Genetic Medici
SHIFT:
Day (United States of America)Seeking Breakthrough Makers
Children’s Hospital of Philadelphia (CHOP) offers countless ways to change lives. Our diverse community of more than 20,000 Breakthrough Makers will inspire you to pursue passions, develop expertise, and drive innovation.
At CHOP, your experience is valued; your voice is heard; and your contributions make a difference for patients and families. Join us as we build on our promise to advance pediatric care—and your career.
CHOP does not discriminate on the basis of race, color, sex, national origin, religion, or any other legally protected categories in any employment, training, or vendor decisions or programs. CHOP recognizes the critical importance of a workforce rich in varied backgrounds and experiences and engages in ongoing efforts to achieve that through equally varied and non-discriminatory means.
A Brief Overview
The Children's Hospital of Philadelphia (CHOP) is dedicated to advancing the development and clinical translation of genome editing and other novel advanced gene therapies. This role plays a key role in advancing CHOP's research priorities and gene therapy programs.
This position collaborates with senior clinical, research, and administrative leaders in strategic planning efforts that drive innovation, advance investigational genome editing programs, and maximize the impact of scientific discoveries. This role also serves as an institutional subject matter expert in regulatory compliance, leading the preparation and submission of pre-IND and IND applications, advising on FDA regulatory requirements, and providing strategic oversight through clinical development to support Biologics License Application (BLA) submission for genome editing-based therapeutics.
Working closely with investigators, institutional leadership, regulatory agencies, and industry collaborators, the position leads scientific and strategic efforts across CHOP's gene therapy portfolio, advancing the discovery, translational development, and early clinical progression of gene therapy and genome editing programs. Success in this role requires expertise in advanced therapeutic development, strong cross-functional leadership, and the ability to mentor scientific and regulatory personnel while advancing transformative genome editing medicines.
What you will do
- Develop regulatory strategies for gene editing and other advanced genetic medicine programs from target discovery through IND-enabling studies and early clinical development
- Direct implementation of the regulatory strategy for gene therapy programs
- Provide regulatory expertise for the long-term scientific and portfolio strategy of gene therapy programs
- Act as the subject matter expert to identify and develop solutions for regulatory requirements in support of major regulatory submission programs as needed, including strategies to progress towards a BLA
- Oversee all gene editing and other innovative gene therapy related regulatory submissions
- Fully accountable for the timely development and submission of regulatory documents (e.g., pre-IND and end-of-phase briefing books, INDs, NDA/BLAs, CTAs, MAAs, responses to regulatory queries, IND safety reports, etc.)
- Communicate directly with regulatory agencies including the US Food and Drug Administration (FDA)
- Advise teams on the CMC and nonclinical aspects of product development
- Contribute to the creation and implementation of clinical development plans designed to maximize the likelihood of successful regulatory applications
- Support sponsor-investigators in the development and writing of the scientific and regulatory rationale for CHOP gene editing study protocols and IND/IDEs (for example, inclusion/exclusion criteria, clinical endpoints, dose justification, dose escalation rationale, etc.)
- Contribute to intellectual property and business development strategy
- In collaboration with faculty and Clinical In Vivo Gene Therapy group members, interact with relevant academic and industry collaborators and serve as key point of contact on behalf of CHOP
- Mentor and help guide junior members of gene therapy regulatory and research teams
- Monitor current and proposed regulatory, scientific, and pertinent legal issues globally, and perform competitive intelligence to provide an assessment of the impact on product development and regulatory approval success
- Ensure programs meet scientific, regulatory, quality, and safety standards
Education Qualifications
- Bachelor's Degree - Required
- Master's Degree - Preferred
Experience Qualifications
- At least twelve (12) years of gene therapy clinical research experience - Required
- At least twelve (12) years of related regulatory experience including gene therapy INDs, BLA preparation and FDA, IRB & other regulatory authority collaboration - Required
- At least twelve (12) years of gene therapy grant writing experience - Required
- At least twelve (12) years of intellectual property development experience - Required
Skills and Abilities
- Advanced proficiency with establishing novel treatment U.S. and E.U. regulatory and clinical strategy and implementation, including from pre-clinical to registration phases across multiple therapeutic areas
- Advanced proficiency with clinical research management, trial conduct, and clinical trial oversight
- Advanced knowledge of FDA and other regulatory agency gene therapy guidelines, including IND/IDE requirements, DSMP and DSMB charter development
- Advanced knowledge of federal, state, and local regulations for human research subject protections including ICH/GLP/GCP/GMP guidelines
- Advanced knowledge of gene therapy regulatory pathways, designations and pharmaceuticals including FDA Orphan Designation, breakthrough therapy and novel potential regulatory pathways
- Advanced knowledge of product manufacturing including related quality assurance & quality control systems
To carry out its mission, CHOP is committed to supporting the health of our patients, families, workforce, and global community. As a condition of employment, CHOP employees who work in patient care buildings or who have patient facing responsibilities must receive an annual influenza vaccine. Learn more.EEO / VEVRAA Federal Contractor | Tobacco Statement
SALARY RANGE:
$100,000.00 - $375,000.00 AnnuallySalary ranges are shown for full-time jobs. If you're working part-time, your pay will be adjusted accordingly.
This job is eligible for an incentive program.At CHOP, we are committed to fair and transparent pay practices. Factors such as skills and experience could result in an offer above the salary range noted in this job posting. Click here for more information regarding CHOP's Compensation and Benefits.
Originally posted on Himalayas